Peter Ellis
Impact in
- Oncology top 0.5%
- Lung Cancer Research Studies
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 96
- Lung Cancer Research Studies 25
- Cancer Treatment and Pharmacology 19
-
- Lung Cancer Treatments and Mutations 40
- Lung Cancer Diagnosis and Treatment 18
- Co-authors
- Phyllis Butow (6 shared papers)Martin H.N. Tattersall (5 shared papers)Andrew Bell (4 shared papers)David Brown (3 shared papers)N.K. Terrett (2 shared papers)Cordelia Langford (10 shared papers)Jackie D. Corbin (1 shared paper)Robert M. Wallis (1 shared paper)
- Journals
- Journal of Clinical Oncology (41 papers)Annals of Oncology (16 papers)Journal of Thoracic Oncology (10 papers)Cancer Research (8 papers)The Journal of Laryngology & Otology (7 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Peter Ellis
519 papers receiving 17.4k citations
Peter Ellis's Hit Papers
Peers
Comparison fields: 5 of 223
- Oncology 3.3k
- Cancer Research 1.8k
- Pulmonary and Respiratory Medicine 2.6k
- Molecular Biology 5.1k
- Immunology 1.1k
Countries citing papers authored by Peter Ellis
This map shows the geographic impact of Peter Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ellis more than expected).
Fields of papers citing papers by Peter Ellis
This network shows the impact of papers produced by Peter Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ellis. The network helps show where Peter Ellis may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Ellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 603 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High burden and pervasive positive selection of somatic mutations in normal human skin Hit paper breakdown → | 2015 | 1195 |
| 2 | G&T-seq: parallel sequencing of single-cell genomes and transcriptomes Hit paper breakdown → | 2015 | 551 |
| 3 | Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction Hit paper breakdown → | 1996 | 545 |
| 4 | Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer Hit paper breakdown → | 2006 | 526 |
| 5 | A Novel CpG Island Set Identifies Tissue-Specific Methylation at Developmental Gene Loci Hit paper breakdown → | 2008 | 503 |
| 6 | 2009 | 467 | |
| 7 | 1999 | 453 | |
| 8 | 2006 | 426 | |
| 9 | 2005 | 403 | |
| 10 | 2003 | 400 | |
| 11 | 2005 | 359 | |
| 12 | 1996 | 343 | |
| 13 | 2012 | 311 | |
| 14 | A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. | 2003 | 309 |
| 15 | 1993 | 250 | |
| 16 | 1990 | 247 | |
| 17 | Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆ Hit paper breakdown → | 2020 | 238 |
| 18 | 2019 | 231 | |
| 19 | 2000 | 218 | |
| 20 | 2007 | 216 |
About Peter Ellis
Peter Ellis is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Public Health, Environmental and Occupational Health and General Health Professions, having authored 603 papers that have together received 18.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Research Studies (25 papers), Breast Cancer Treatment Studies (22 papers), Cancer Genomics and Diagnostics (22 papers), Palliative Care and End-of-Life Issues (21 papers), Cancer Treatment and Pharmacology (19 papers), Lung Cancer Diagnosis and Treatment (18 papers) and Legal Rights and Human Rights (16 papers). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (1.8k citations), Pulmonary and Respiratory Medicine (2.6k citations), Molecular Biology (5.1k citations) and Immunology (1.1k citations). Peter Ellis has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include Phyllis Butow, Martin H.N. Tattersall, Andrew Bell, David Brown, N.K. Terrett, Cordelia Langford, Jackie D. Corbin, Robert M. Wallis, Sharron H. Francis and Mark Roberts. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Cancer Research and The Journal of Laryngology & Otology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.